Keyword: GlaxoSmithKline (GSK)

News

Whistleblower Rule Clears Divided U.S. SEC

26.05.2011 - Corporate whistleblowers could score multi-million-dollar payouts for reporting financial wrongdoing under a new program approved by U.S. securities regulators on Wednesday. A...

News

India's Sun Pharma, US Merck in Generics Joint Venture

12.04.2011 - U.S. drugmaker Merck & Co has formed a joint venture with India's Sun Pharmaceutical Industries Ltd to develop and manufacture branded generic drugs for emerging markets, the two...

News

No Proof Of Drug Industry Sway On WHO In Pandemic

11.03.2011 - Independent experts who examined the World Health Organization's handling of the H1N1 pandemic said on Thursday they had found no evidence of drug industry influence on the U.N...

Strategy & Management

Oracle’s Agile PLM Reorganizes Pharma, From Lab to Launch

26.01.2011 - Becoming Nimble - It's no secret that Big Pharma is facing some of the biggest changes in the history of the industry. The looming patent cliff is now forcing companies to...

News

Rx-360 Continues to Intensify Work in 2011

19.01.2011 - Looking Ahead - Rx-360 turns two years old this month, and the international supply chain consortium can look back on a host of achievements. The group now boasts over 50...

News

EU Presses Pharma Companies for More Info on Patent Deals

18.01.2011 - EU regulators said on Monday they were pressing pharmaceutical companies for more information on their patent deals with generic companies to make sure there is no delay in cheaper...

News

Anne Phillips Appointed VP of Novo Nordisk's Clinical Development, Medical and Regulatory Affairs for North America

04.01.2011 - Anne Phillips, M.D., has been appointed as Novo Nordisk's as vice president, Clinical Development, Medical and Regulatory Affairs for North America. Dr. Phillips reports directly...

News

Ribena Site: GSK May Face Industrial Action

22.12.2010 - Workers at GlaxoSmithKline's Ribena factory in central England will vote on Wednesday over possible industrial action to protest at the refusal of Britain's biggest drugmaker to...